These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10657247)

  • 21. Role of protein conformational mobility in enzyme catalysis: acylation of alpha-chymotrypsin by specific peptide substrates.
    Hengge AC; Stein RL
    Biochemistry; 2004 Jan; 43(3):742-7. PubMed ID: 14730979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divalent metal ions influence catalysis and active-site accessibility in the cAMP-dependent protein kinase.
    Adams JA; Taylor SS
    Protein Sci; 1993 Dec; 2(12):2177-86. PubMed ID: 8298463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Base-sequence specificity of Hoechst 33258 and DAPI binding to five (A/T)4 DNA sites with kinetic evidence for more than one high-affinity Hoechst 33258-AATT complex.
    Breusegem SY; Clegg RM; Loontiens FG
    J Mol Biol; 2002 Feb; 315(5):1049-61. PubMed ID: 11827475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
    Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the role of tightly bound phosphoenolpyruvate in Escherichia coli 3-deoxy-d-manno-octulosonate 8-phosphate synthase catalysis using quantitative time-resolved electrospray ionization mass spectrometry in the millisecond time range.
    Li Z; Sau AK; Furdui CM; Anderson KS
    Anal Biochem; 2005 Aug; 343(1):35-47. PubMed ID: 15979047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis.
    Baranovskii AG; Ershova NA; Buneva VN; Kanyshkova TG; Mogelnitskii AS; Doronin BM; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    Immunol Lett; 2001 Apr; 76(3):163-7. PubMed ID: 11306143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catalytic mechanism of glucoamylase probed by mutagenesis in conjunction with hydrolysis of alpha-D-glucopyranosyl fluoride and maltooligosaccharides.
    Sierks MR; Svensson B
    Biochemistry; 1996 Feb; 35(6):1865-71. PubMed ID: 8639668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amidase and peptidase activities of polyclonal immunoglobulin G present in the sera of patients with rheumatoid arthritis.
    Matsuura K; Ikoma S; Sugiyama M; Funauchi M; Sinohara H
    Appl Biochem Biotechnol; 2000; 83(1-3):107-13; discussion 113-4, 145-53. PubMed ID: 10826953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catalytic antibodies: evolution of protein function in real time.
    Lerner RA; Janda KD
    EXS; 1995; 73():121-38. PubMed ID: 7579971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
    Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
    J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Substrate binding mechanism of Glu180-->Gln, Asp176-->Asn, and wild-type glucoamylases from Aspergillus niger.
    Christensen U; Olsen K; Stoffer BB; Svensson B
    Biochemistry; 1996 Nov; 35(47):15009-18. PubMed ID: 8942667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyclonal antibodies and catalysis.
    Stephens DB; Wilmore BH; Iverson BL
    Bioorg Med Chem; 1994 Jul; 2(7):653-8. PubMed ID: 7858972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catalytic antibodies: a critical assessment.
    Tawfik DS; Eshhar Z; Green BS
    Mol Biotechnol; 1994 Feb; 1(1):87-103. PubMed ID: 7859154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyclonal catalytic antibodies.
    Ostler EL; Resmini M; Brocklehurst K; Gallacher G
    J Immunol Methods; 2002 Nov; 269(1-2):111-24. PubMed ID: 12379356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.